首页> 外文OA文献 >Phase I and Pharmacokinetic Study of ABI-007, Albumin-bound Paclitaxel, Administered Every 3 Weeks in Japanese Patients with Solid Tumors

【2h】

Phase I and Pharmacokinetic Study of ABI-007, Albumin-bound Paclitaxel, Administered Every 3 Weeks in Japanese Patients with Solid Tumors

机译：日本实体瘤患者每3周进行ABI-007（与白蛋白结合的紫杉醇）的I期和药代动力学研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yamada, Kazuhiko; Yamamoto, Noboru; Yamada, Yasuhide; Mukohara, Toru; Minami, Hironobu; Tamura, Tomohide;
展开▼
作者单位

展开▼
年度 2010
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. Phase I and pharmacokinetic study of ABI-007, albumin-bound paclitaxel, administered every 3 weeks in Japanese patients with solid tumors. [J] . Yamada K, Yamamoto N, Yamada Y, Japanese journal of clinical oncology. . 2010,第5期

机译：日本实体瘤患者每3周进行一次ABI-007（白蛋白结合的紫杉醇）的I期和药代动力学研究。
2. Phase I and Pharmacokinetic Study of ABI-007, Albumin-bound Paclitaxel, Administered Every 3 Weeks in Japanese Patients withn Solid Tumors [J] . Tomohide Tamura Japanese Journal of Clinical Oncology . 2010,第5期

机译：日本实体瘤患者每3周进行ABI-007（白蛋白结合的紫杉醇）的I期和药代动力学研究
3. Phase i and pharmacokinetic study of nab-paclitaxel, nanoparticle albumin-bound paclitaxel, administered weekly to Japanese patients with solid tumors and metastatic breast cancer [J] . AndoM., YonemoriK., KatsumataN., Cancer chemotherapy and pharmacology. . 2012,第2期

机译：纳贝-紫杉醇（纳米颗粒白蛋白结合的紫杉醇）的第一阶段和药代动力学研究，每周向日本患有实体瘤和转移性乳腺癌的患者给药
4. Pharmacokinetic study of a systemically administered novel liposomal Temoporfln formulation in an animal tumor model [C] . Jenny Svensson, Ann Johansson, Niels Bendsoe, Optical Methods for Tumor Treatment and Detection: Mechanisms and Techniques in Photodynamic Therapy XVI; Progress in Biomedical Optics and Imaging; vol.8 no.4; Proceedings of SPIE-The International Society for Optical Engineering; vol.6427 . 2007

机译：在动物肿瘤模型中全身施用新型脂质体替莫泊芬制剂的药代动力学研究
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Phase I and Pharmacokinetic Study of ABI-007 Albumin-bound Paclitaxel Administered Every 3 Weeks in Japanese Patients with Solid Tumors [O] . Kazuhiko Yamada, Noboru Yamamoto, Yasuhide Yamada, -1

机译：日本实体瘤患者每3周进行ABI-007（与白蛋白结合的紫杉醇）的I期和药代动力学研究
7. An open-label, dose-escalation, safety, and pharmacokinetics phase I study of ombrabulin, a vascular disrupting agent, administered as a 30-min intravenous infusion every 3 weeks in Japanese patients with advanced solid tumors [O] . H. Murakami, T. Kurata, Y. Onozawa, 2014

机译：一项开放性，剂量递增，安全性和药代动力学I期研究ombrabulin（一种血管破裂剂），在日本患有晚期实体瘤的患者中每3周静脉输注30分钟

Phase I and Pharmacokinetic Study of ABI-007, Albumin-bound Paclitaxel, Administered Every 3 Weeks in Japanese Patients with Solid Tumors

著录项

引文网络

相似文献

相关主题

期刊订阅